Advertise your Pathology Conferences and Webinars with us!
To reach the 8,000 monthly visitors of this page, email your text, graphics and contact information to Ads@PathologyOutlines.com. If no response within 1 business day, please resend and CC Rosie@PathologyOutlines.com. Ads are posted until the conference / webinar date. Email us once you have the date and we will create a Save the Date ad to use until you get your official ad; there is no additional charge for changes or for rescheduling due to the COVID-19 pandemic. After posting, we will send you a confirmation email and invoice; please use the link at the bottom of the invoice to pay. Prepayment may be required.
We have these options for posting:
(a) $700 for a highlighted listing (most of the ads below are highlighted listings) with graphics, text and links
(b) $400 for a one line listing (date, location, title and link)
(c) $1,000 to add an E-blast (example) or social media posting
(d) $1,500 to add a premium E-blast (more visitors, different options for ad, contact us for details)
(e) $750 to add a banner for one month on the Conferences page (top: 728x90, side: 300x250)
(f) Package of 6 highlighted listings plus one E-blast or social media posting plus an Organization listing, contact us
(g) Contact us for additional promotional packages
Links to all recent posts are included in an E-blast sent biweekly to 6,570 subscribers for no additional charge. Frequently asked questions Testimonials
Map of US with regions
USCAP Presents:
A Contemporary Approach and Update on the Classification, Grading, Staging and Reporting of GU Tumors
Classification, grading, staging and reporting of GU tumors continue to evolve with the discovery of pathogenic mechanisms and the advent of novel diagnostic tools and therapies. It is imperative for practicing pathologists to keep pace with the important changes in GU tumor pathology in order to produce pathology diagnoses and reports that meet contemporary patient management needs. Examples requiring educational focus are the significant error rate and inter-observer variability in the diagnosis of cribriform carcinoma and intraductal carcinoma of prostate; under-recognition and under-reporting of bladder cancer variants; misclassification of testicular germ cell tumors correlated with drastic revision of WHO 2016 classification; modifications in prostate grading correlative with newly described morphologic changes, new outcome data and adjustment to the modified Gleason grading system; changes in GU tumor staging following publication of the 8th edition of the AJCC Staging guidelines; requisite refinements in cancer reporting to eliminate significant variation, error, and missing relevant elements. This course is a pragmatic exercise in mentoring for advanced learning taught by international experts who reflect USCAP’s gold standard.
Course Location: Palm Springs, CA
Course Director:
Ming Zhou, MD, PhD
USCAP Presents:
Practical Issues in Urologic Pathology - 40 New Cases!
Specimens represented by prostate needle core biopsies, transurethral resection of prostate (TURP), radical prostatectomy, kidney biopsies, nephrectomy (radical or partial), bladder biopsies, cystectomy (radical or partial), cystoprostatectomy, testicular biopsies or orchiectomy are frequently handled by pathology residents/fellows, general surgical pathologists and/or urologic pathologists in academic institutions and private practices. These specimens are associated with potential diagnostic challenges and risks in day-to-day practice. This experienced faculty has selected exemplary cases from their expert consultation files (and routine in-house cases) that illustrate recurrent professional practice gaps in urologic pathology. Through intimate mentoring, you will learn how to approach them, make accurate diagnoses, and avoid traps and pitfalls that could cause diagnostic error. The course is pragmatic, clinically-oriented and stimulating. It will focus on these issues:
• Benign tumor-like lesions of the prostate are often over-diagnosed as prostate cancer or atypical small acinar proliferations
• Secondary tumors involving the prostate are frequently misdiagnosed as prostate cancer
• Histological variants of prostate cancer with important clinical significance are under-recognized
• Therapy-related changes in benign glands and prostate cancer are frequently missed
• Extra-prostatic extension in prostate needle core biopsies is frequently missed
• Recently described renal carcinomas are not well-appreciated
• Secondary tumors involving the kidney are occasionally misinterpreted as primary tumors
• Some variants of urothelial carcinoma are under-recognized
• Benign entities that mimic urothelial carcinoma are frequently misdiagnosed
• Testicular tumors still continue to pose diagnostic challenges
Course Location: Palm Springs, CA
Course Director:
Adeboye O. Osunkoya
